MATERIALS AND METHODS

Materials.
Highly purified human urinary high mol wt urokinase and low mol wt urokinase were prepared by the method previously described.7
The high mol wt urokinase had a mol wt of 54,000, with 93% active sites by p-nitrophenyl-p'-guanidinobenzoate titration, and a specific activity of I 16,000 lU/mg protein. The low mol wt urokinase had a molecular weight of 33,000, with 95% active sites, and a specific activity of 227,000 lU/mg protein. Dog urinary urokinase was prepared from 5,500 mL beagle bladder urine by adsorption and elution from aluminum magnesium silicate followed by adsorption and elution from p-amino-benzamidine-Sepharose8 and gel filtration on Sephadex G-100. A plasma sample (100 mL, 1.6 x l0 dpm, 380 IU), from blood drawn 45 minutes after intraduodenal administration of the urokinase sample, was applied to an ACHSepharose affinity chromatography column (1.9 x 7.0 cm), and the column was washed with 2 mol/L NaCl/0.l mol/L phosphate buffer, pH 7.4, and eluted with the same buffer containing 8 mol/L urea.5'7 The adsorbed-eluted fraction was dialyzed against 5 mmol/L NH4HCO3 and concentrated with polyethylene glycol 20,000. A second affinity chromatography step with the specific anti-human low mol wt urokinase IgG-Sepharose CL-4B column (2 mL resin) was used to purify the urokinase-type proteins further.
The ACHSepharose adsorbed-eluted fraction (13 mL; 5 x l0 dpm, 2,930 IU) was applied to the column, washed with the 0.1 mol/L Tris/ phosphate buffer containing 2 mol/L NaCI, pH 8.0, and eluted with an 8 mol/L urea/0.l mol/L Tris/phosphate buffer containing 2 mol/L NaCI, pH 8.0. The unadsorbed and adsorbed-eluted fractions from the immuno-affinity column were dialyzed against 5 mmol/L NH4HCO3 and lyophilized. The control plasma after administration of5 mL of0.9% NaCl was also processed as described above. Protein was determined from absorbency measurement at 280 nm, assuming an E ,,mOf
13.2.
Immuno-affinity unadsorbed (48 mg) and adsorbed (1 .1 mg) fractions were dissolved in 1 mL and 3 mL ofO.l mol/L NH4HCO3, respectively, and the insoluble material was removed by centrifugation at 1,850 g for ten minutes at 4 #{176}C. Each supernatant was gel-filtered on Sephacryl 5-300 (1.5 x 95 cm) in 0.1 mol/L NH4HCO3.
One milliliter of the unadsorbed fraction (25,000 dpm, 2,500 IU, 48 mg protein) was applied to the column and eluted with 0.1 mol/L NH4HCO3; 1 mL of the adsorbed-eluted fraction (7,500 dpm, 5 IU, 350 j.tg protein) equivalent to a third of the total vol was also applied to the column and eluted with 0.1 mol/L NH4HCO3. The 2-mL effluent fractions were monitored for protein by absorbency measurements at 280 nm, for radioactivity in dpm, for UK-amidolytic activity with 5-2444 amidolytic assay, and for Glu-Plg activator activity with 5-225 1 amidolytic assay. SDS-PAGE was performed using a I 1.1% slab gel (12 x 13 mm, 1-mm thick) at constant current of 30 mA for 2.5 hours. After electrophoresis of immunoaffinity adsorbed-eluted fraction, the gel was sliced into 2.0-mm sections, and the radioactivity ofeach gel slice was counted. Another gel lane was placed on the plasminogen-rich fibrin-agarose plate according to Granelli-Piperno and Reich'5 for zymographic analysis. ; determining the distribution of radioactivity (Fig 6B) . The The unadsorbed and adsorbed-eluted fractions obtained in the immuno-affinity step (Fig  3) , and dog urinary urokinase were each mixed with specific anti-low mol wt urokinase IgG, and the activator activity of the mixture was measured on a plasminogen-rich fibrin-agarose plate.
RESULTS
Absorption
As shown in Fig 7, 
